About Us
History
Leaders
Awards and Accolades
Career
Contact Us
People
LEADERSHIP TEAM
Core Investigators
Joint Investigators
Adjunct Investigators
Science
Cancer Signalling & Therapy
Cell & Molecular Therapy
Neurometabolism in Health & Disease
Technology Platforms
Programmes
News and Events
News
Events
Home
A*STAR IMCB
News and Events
News
A*STAR IMCB
About Us
History
Leaders
Awards and Accolades
Career
Contact Us
People
LEADERSHIP TEAM
Core Investigators
Joint Investigators
Adjunct Investigators
Science
Cancer Signalling & Therapy
Cell & Molecular Therapy
Neurometabolism in Health & Disease
Technology Platforms
Programmes
News and Events
News
Events
News
Filter by Sub-Category, Tag and Year
22 May 2026
Zeroing in on the Root of Gastric Cancer
21 May 2026
Unbinding the “Undruggable”: How Molecular Glues Could Change the Way We Treat Disease
25 Mar 2026
Study identifies novel pan-TEAD inhibitors to overcome drug resistance in cancer
27 Jan 2026
Study reveals early abnormalities in liver cells derived from clinically healthy SMA carriers
22 Jan 2026
SINGAPORE SCIENTISTS DISCOVER LUNG CANCER'S "BODYGUARD SYSTEM" – AND HOW TO DISARM IT
19 Dec 2025
SINGAPORE SCIENTISTS SHOW TARGETING CANCER STEM CELLS CAN PREVENT GASTRIC CANCER RECURRENCE
05 Dec 2025
A*STAR IMCB Researcher Honoured with the L’Oréal–UNESCO For Women in Science Award
13 Oct 2025
SINGAPORE SCIENTISTS IDENTIFY MARKERS OF KEY STEM CELL POPULATIONS DRIVING COLORECTAL CANCER FORMATI
...
25 Sep 2025
Celebrating Postdocs at A*STAR IMCB’s Inaugural Symposium
08 Sep 2025
New Colon Cancer Models Pinpoint Stem Cells as Cancer Origins
21 Jul 2025
SINGAPORE RESEARCHERS DEVELOP AI TOOL TO PREDICT LIVER CANCER RECURRENCE
14 Jul 2025
Singapore-Developed Cancer Drug Shows Promise as Treatment for Blindness
14 Jul 2025
A*STAR IMCB Scientists Develop Proteomics Pipeline to Strengthen Safety of Alternative Proteins
20 May 2025
Phase II Trial Completed – Singapore’s New Anti-Cancer Drug One Step Away from Market
13 May 2025
Unlocking Pluripotency: What Powers a Stem Cell’s Identity?
09 May 2025
SINGAPORE-DEVELOPED CANCER IMMUNOTHERAPY OFFERS NEW HOPE FOR LATE-STAGE CANCER PATIENTS
24 Apr 2025
A*STAR IMCB Researchers Awarded NRF CRP Funding to Advance Research in Neurodegeneration and Drug Re
...
21 Apr 2025
Local Scientific Research Uncovers Why Melanoma Is Hard to Treat, Plans to Partner with Pharmaceutic
...
10 Apr 2025
A*STAR IMCB CELEBRATES 40 YEARS OF BIOMEDICAL INNOVATION AND IMPACT
16 Jan 2025
Unlocking New Therapeutic Pathways: PRL1 and PRL3 in Tumour Growth and Cancer Immunotherapy
View more